153 related articles for article (PubMed ID: 2089792)
1. [The role of the thrombocyte and erythrocyte components of hemostasis in the development of thrombohemorrhagic complications in patients with systemic lupus erythematosus].
Gritsiuk AI; Ivanova NV; Vas'kova NG; Kosiuk LN; Poltavets NI
Vrach Delo; 1990 Dec; (12):21-3. PubMed ID: 2089792
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of the thrombohemorrhagic syndrome in patients with systemic lupus erythematosus].
Angelutsa PA; Ivanova NV; Vasil'ev VV; Vas'kova NG; Kosiuk LN
Vrach Delo; 1989 Jan; (1):50-2. PubMed ID: 2718447
[TBL] [Abstract][Full Text] [Related]
3. [The thrombocyte link in blood-coagulation homeostasis in patients with systemic lupus erythematosus].
Vas'kova NG
Vrach Delo; 1990 Nov; (11):51-3. PubMed ID: 2098984
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostics and correction of thrombohemorrhagic impairments in patients with purulent-septic complications in obstetrics and gynecology].
Kolesnichenko AP; Gritsan GV; Gritsan AI; Skorobogatov AIu
Anesteziol Reanimatol; 2004; (4):41-4. PubMed ID: 15468555
[TBL] [Abstract][Full Text] [Related]
5. [Thrombohemorrhagic syndrome in systemic lupus erythematosus].
Iakimova NIa; Sukhanov AA
Klin Med (Mosk); 1974 Jan; 52(1):37-41. PubMed ID: 4466883
[No Abstract] [Full Text] [Related]
6. [Status of fibrinolysis in systemic lupus erythematosus].
Ihle E; Ziemer S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):184-90. PubMed ID: 2427400
[TBL] [Abstract][Full Text] [Related]
7. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
Pribytkov IuN; Poltyrev AS; Shilkina NP
Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
[No Abstract] [Full Text] [Related]
8. [Circulating anticoagulants in systemic lupus. Apropos of 60 patients. Multicenter study conducted by the research department of the SNFMI].
Le Thi Huong Du; Guillevin L; Arlet Suau E; Bercoff E; Pasquali JL; Beylot J; Kaloustian E; Garabedian C; Agius D; Beaugrand M
Ann Med Interne (Paris); 1987; 138(4):246-50. PubMed ID: 3115165
[No Abstract] [Full Text] [Related]
9. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
[TBL] [Abstract][Full Text] [Related]
10. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
[No Abstract] [Full Text] [Related]
11. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.
Carreras LO; Vermylen JG
Thromb Haemost; 1982 Aug; 48(1):38-40. PubMed ID: 6813993
[TBL] [Abstract][Full Text] [Related]
12. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
[TBL] [Abstract][Full Text] [Related]
13. Haemorheological changes in patients with systemic lupus erythematosus do not seem to be related to thrombotic events.
Vayá A; Murado J; Santaolaria M; Simó M; Micó L; Calvo J; Todolí J; Ricart JM
Clin Hemorheol Microcirc; 2008; 38(1):23-9. PubMed ID: 18094455
[TBL] [Abstract][Full Text] [Related]
14. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
15. Lethal manifestations of systemic lupus erythematosus in a forensic context.
Nicklin A; Byard RW
J Forensic Sci; 2011 Mar; 56(2):423-8. PubMed ID: 21306376
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
18. [Coagulation and acute disseminated lupus erythematosus. Apropos of 25 cases].
Godeau P; Herreman G; Raby C; Levassor M
Sem Hop; 1977 Mar; 53(10):609-12. PubMed ID: 194314
[TBL] [Abstract][Full Text] [Related]
19. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
20. [A histochemical evaluation of thrombocyte metabolism in systemic lupus erythematosus].
Kozlovskaia NL; Artem'eva VB; Kuznetsov SL; Kabaenkova GS; Kozlovskaia LV
Ter Arkh; 1994; 66(6):35-6. PubMed ID: 7940363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
